Moyamoya disease (MMD): investigations
Evidence-based neurology checklist on moyamoya disease (mmd): investigations: Genetic testing RFN213 p.R4810K: in all patients Digital subtraction angiography (DSA) Magnetic resonance imaging (MRI) brain: features High resolution intracranial vessel wall imaging (HRIVWI)
Genetic testing
- RFN213 p.R4810K: in all patients
Digital subtraction angiography (DSA)
Magnetic resonance imaging (MRI) brain: features
High resolution intracranial vessel wall imaging (HRIVWI)
References
- Kraemer M, Heienbrok E, Berlit P. Moyamoya disease in Europeans. Stroke 2008; 39:3193-3200.
- Bersano A, Khan N, Fuentes B, et al. European Stroke Organisation (ESO) guidelines on moyamoya angiopathy endorsed by vascular European reference network (VASCERN). Eur Stroke J 2023; 8:55-84.
- Ohta T, Tanaka H, Kuroiwa T. Diffuse leptomeningeal enhancement, “ivy sign”, in magnetic resonance images of moaymoya disease in childhood: case report. Neurosurgery 1995; 37:1009-1012.
- Wang LX, Wang H, Hao FB, et al. Ivy sign in moyamoya disease: a comparative study of the FLAIR vascular hyperintensity sign against contrast-enhanced MRI. Am J Neuroradiol 2021; 42:694-700.
- Kathuveetil A, Sylaja PN, Senthilvelan S, Kesavadas C, Banerjee M, Jayanand Sudhir B. Vessel wall thickening and enhancement in high-resolution intracranial vessel wall imaging: a predictor of future ischemic events in moyamoya disease. AJNR 2020; 41:100-105.
- And 1 more. Subscribe to see the full list
